Report Detail
Global Anti-Peptic Ulcer Drugs Market Growth 2019-2024
- RnM2930415 |
- 12 February, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
China’s anti-trust crackdown on foreign pharmaceutical companies has left many foreign investors in the healthcare industry shocked. The Chinese government has had no qualms about openly stating that it prefers hospitals to purchase from domestic producers. That said, China’s homegrown manufacturers of medical devices and medicine still lack the sophistication to produce many of the more advanced health care products the country needs. Amid rising living standards and an aging population, China’s healthcare needs are set to rise sharply in the coming years.
In April 2015, China amended its Drug Administration Law, introducing two major changes.
The first is a simplification of the company set-up procedure for pharmaceutical companies. Prior to the amendment, investors that wanted to manufacture or distribute pharmaceuticals needed to have a Drug Manufacturing License or a Drug Distribution License before applying for a business license. Now, investors may apply for these after the company has been set up, significantly speeding up the incorporation process.
More importantly, the amendment removes the price controls that the Chinese government had in place for medicines. As of the year 2000, medicines that were listed on the government’s Medical Insurance Catalog, and those medicines on which there was a monopoly, had their prices fixed or guided by the government. About 23 percent of the medicines on the Chinese market had government fixed or guided prices. The price of other medicines was left to market forces. While these price restrictions are now fully removed, companies still need to abide by China’s anti-trust laws. Companies abusing their dominant market position are still punishable under Chinese law.
While recent moves have made it easier for foreign investors to introduce new medical products to the Chinese market, the Chinese government has at the same time placed restraints on advertising healthcare products. The final text of the revised Advertising Law was released by the National People’s Congress, China main legislative body, in late April 2015. The law comes into force in September 2015.
The 2015 Advertising Law has special stipulations about advertising for medicine and medical devices. For one, advertising for anesthetics, psychotropic drugs, toxic and radioactive drugs for medical use is not allowed, nor is advertisement for drugs, treatment plans and medical devices to combat drug addiction. Advertising for prescription drugs other than those mentioned previously is only allowed in professional medical journals.
The content for medical advertisements is regulated as well. Any advertisement for drugs, medical treatment or medical devices may not contain the following:
According to this study, over the next five years the Anti-Peptic Ulcer Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anti-Peptic Ulcer Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Peptic Ulcer Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the Anti-Peptic Ulcer Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Ulcer Protective Drugs
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Ask-pharm
Takeda
Yangtze River Pharm
Shandong Luoxin
Huadong Medicine
Changzhou Siyao
Beijing Yuekang
Guangdong Dahua
Xian Janssen
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Anti-Peptic Ulcer Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Anti-Peptic Ulcer Drugs market by identifying its various subsegments.
Focuses on the key global Anti-Peptic Ulcer Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-Peptic Ulcer Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Anti-Peptic Ulcer Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Anti-Peptic Ulcer Drugs Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Anti-Peptic Ulcer Drugs Consumption 2014-2024
- 2.1.2 Anti-Peptic Ulcer Drugs Consumption CAGR by Region
- 2.2 Anti-Peptic Ulcer Drugs Segment by Type
- 2.2.1 Proton Pump Inhibitors (PPIs)
- 2.2.2 Potassium-Competitive Acid Blockers (P-CAB)
- 2.2.3 Antacids
- 2.2.4 H2 Antagonists
- 2.2.5 Ulcer Protective Drugs
- 2.3 Anti-Peptic Ulcer Drugs Consumption by Type
- 2.3.1 Global Anti-Peptic Ulcer Drugs Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Anti-Peptic Ulcer Drugs Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Anti-Peptic Ulcer Drugs Sale Price by Type (2014-2019)
- 2.4 Anti-Peptic Ulcer Drugs Segment by Application
- 2.4.1 Gastritis
- 2.4.2 Gastric Ulcers
- 2.4.3 Duodenal Ulcers
- 2.4.4 Gastroesophageal Reflux Disease (GERD)
- 2.5 Anti-Peptic Ulcer Drugs Consumption by Application
- 2.5.1 Global Anti-Peptic Ulcer Drugs Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Anti-Peptic Ulcer Drugs Value and Market Share by Application (2014-2019)
- 2.5.3 Global Anti-Peptic Ulcer Drugs Sale Price by Application (2014-2019)
3 Global Anti-Peptic Ulcer Drugs by Players
- 3.1 Global Anti-Peptic Ulcer Drugs Sales Market Share by Players
- 3.1.1 Global Anti-Peptic Ulcer Drugs Sales by Players (2017-2019)
- 3.1.2 Global Anti-Peptic Ulcer Drugs Sales Market Share by Players (2017-2019)
- 3.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Players
- 3.2.1 Global Anti-Peptic Ulcer Drugs Revenue by Players (2017-2019)
- 3.2.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Players (2017-2019)
- 3.3 Global Anti-Peptic Ulcer Drugs Sale Price by Players
- 3.4 Global Anti-Peptic Ulcer Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Anti-Peptic Ulcer Drugs Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Anti-Peptic Ulcer Drugs Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Anti-Peptic Ulcer Drugs by Regions
- 4.1 Anti-Peptic Ulcer Drugs by Regions
- 4.1.1 Global Anti-Peptic Ulcer Drugs Consumption by Regions
- 4.1.2 Global Anti-Peptic Ulcer Drugs Value by Regions
- 4.2 Americas Anti-Peptic Ulcer Drugs Consumption Growth
- 4.3 APAC Anti-Peptic Ulcer Drugs Consumption Growth
- 4.4 Europe Anti-Peptic Ulcer Drugs Consumption Growth
- 4.5 Middle East & Africa Anti-Peptic Ulcer Drugs Consumption Growth
5 Americas
- 5.1 Americas Anti-Peptic Ulcer Drugs Consumption by Countries
- 5.1.1 Americas Anti-Peptic Ulcer Drugs Consumption by Countries (2014-2019)
- 5.1.2 Americas Anti-Peptic Ulcer Drugs Value by Countries (2014-2019)
- 5.2 Americas Anti-Peptic Ulcer Drugs Consumption by Type
- 5.3 Americas Anti-Peptic Ulcer Drugs Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Anti-Peptic Ulcer Drugs Consumption by Countries
- 6.1.1 APAC Anti-Peptic Ulcer Drugs Consumption by Countries (2014-2019)
- 6.1.2 APAC Anti-Peptic Ulcer Drugs Value by Countries (2014-2019)
- 6.2 APAC Anti-Peptic Ulcer Drugs Consumption by Type
- 6.3 APAC Anti-Peptic Ulcer Drugs Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Anti-Peptic Ulcer Drugs by Countries
- 7.1.1 Europe Anti-Peptic Ulcer Drugs Consumption by Countries (2014-2019)
- 7.1.2 Europe Anti-Peptic Ulcer Drugs Value by Countries (2014-2019)
- 7.2 Europe Anti-Peptic Ulcer Drugs Consumption by Type
- 7.3 Europe Anti-Peptic Ulcer Drugs Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Anti-Peptic Ulcer Drugs by Countries
- 8.1.1 Middle East & Africa Anti-Peptic Ulcer Drugs Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Anti-Peptic Ulcer Drugs Value by Countries (2014-2019)
- 8.2 Middle East & Africa Anti-Peptic Ulcer Drugs Consumption by Type
- 8.3 Middle East & Africa Anti-Peptic Ulcer Drugs Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Anti-Peptic Ulcer Drugs Distributors
- 10.3 Anti-Peptic Ulcer Drugs Customer
11 Global Anti-Peptic Ulcer Drugs Market Forecast
- 11.1 Global Anti-Peptic Ulcer Drugs Consumption Forecast (2019-2024)
- 11.2 Global Anti-Peptic Ulcer Drugs Forecast by Regions
- 11.2.1 Global Anti-Peptic Ulcer Drugs Forecast by Regions (2019-2024)
- 11.2.2 Global Anti-Peptic Ulcer Drugs Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Anti-Peptic Ulcer Drugs Forecast by Type
- 11.8 Global Anti-Peptic Ulcer Drugs Forecast by Application
12 Key Players Analysis
- 12.1 AstraZeneca
- 12.1.1 Company Details
- 12.1.2 Anti-Peptic Ulcer Drugs Product Offered
- 12.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 AstraZeneca News
- 12.2 Ask-pharm
- 12.2.1 Company Details
- 12.2.2 Anti-Peptic Ulcer Drugs Product Offered
- 12.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Ask-pharm News
- 12.3 Takeda
- 12.3.1 Company Details
- 12.3.2 Anti-Peptic Ulcer Drugs Product Offered
- 12.3.3 Takeda Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Takeda News
- 12.4 Yangtze River Pharm
- 12.4.1 Company Details
- 12.4.2 Anti-Peptic Ulcer Drugs Product Offered
- 12.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Yangtze River Pharm News
- 12.5 Shandong Luoxin
- 12.5.1 Company Details
- 12.5.2 Anti-Peptic Ulcer Drugs Product Offered
- 12.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Shandong Luoxin News
- 12.6 Huadong Medicine
- 12.6.1 Company Details
- 12.6.2 Anti-Peptic Ulcer Drugs Product Offered
- 12.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Huadong Medicine News
- 12.7 Changzhou Siyao
- 12.7.1 Company Details
- 12.7.2 Anti-Peptic Ulcer Drugs Product Offered
- 12.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Changzhou Siyao News
- 12.8 Beijing Yuekang
- 12.8.1 Company Details
- 12.8.2 Anti-Peptic Ulcer Drugs Product Offered
- 12.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Beijing Yuekang News
- 12.9 Guangdong Dahua
- 12.9.1 Company Details
- 12.9.2 Anti-Peptic Ulcer Drugs Product Offered
- 12.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Guangdong Dahua News
- 12.10 Xian Janssen
- 12.10.1 Company Details
- 12.10.2 Anti-Peptic Ulcer Drugs Product Offered
- 12.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Xian Janssen News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Anti-Peptic Ulcer Drugs . Industry analysis & Market Report on Anti-Peptic Ulcer Drugs is a syndicated market report, published as Global Anti-Peptic Ulcer Drugs Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Anti-Peptic Ulcer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
